Worth reading
39Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
61.7
Year-on-year change in operating income (%)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPNet Sales17,698¥ millionYear on year +18.4%Progress 52.8%
Operating profit575¥ millionYear on year +61.7%Progress 41.1%
Ordinary income651¥ millionYear on year +61.9%Progress 44.0%
Net income attributable to owners of the parent412¥ millionYear on year +92.2%Progress 45.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥53.70
Financial position at period-end
Total assets22,977¥ million
of which net assets 16,278 ¥ millionEquity ratio 70.8%vs. prior year-end +1.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueLiving business ¥12,247.53 thousand (YoY +23.6%), Aqua business ¥667.79 thousand (YoY +1.2%), Medical and Industrial Gases business ¥4,783.65 thousand (YoY +9.1%)
Segment profitLiving business ¥207.34 thousand (YoY +157.9%), Aqua business ¥33.42 thousand (YoY -26.3%), Medical and Industrial Gases business ¥335.24 thousand (YoY +45.5%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥33,500 million (YoY +2.5%)
Operating profit¥1,400 million (YoY +7.7%)
Ordinary income¥1,480 million (YoY +5.6%)
Net income¥900 million (YoY -6.3%)
Annual Dividend Forecast¥29 → ¥30（+3.4%）
Factors Behind Changes in Business Performance
Higher selling prices linked to LP gas procurement prices, increased LP gas shipment volumes, increased rentals of home healthcare equipment, and higher sales in the industrial gases and equipment division.
Disclosure regarding the going concern assumption
No applicable items
Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name No applicable items
Impairment lossNo applicable items
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥6,004 thousand / Extraordinary loss Loss on sale and disposal of non-current assets ¥14,153 thousand
Availability of Supplementary Financial Results MaterialsNone
Availability of Financial Results BriefingNone
Issued Shares at Period-End8,046,500 shares
Treasury Shares at Period-End347,445 treasury shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥17,698 million (YoY +18.4%) |
| Operating profit | ¥575 million (YoY +61.7%) |
| Ordinary income | ¥651 million (YoY +61.9%) |
| Profit attributable to owners of the parent | ¥412 million (YoY +92.2%) |
| Net income per share | ¥53.70 |
| Equity ratio | End of the current fiscal period 70.8 / End of previous period 68.9 |
| Total assets | ¥22,977 million |
| Net assets | ¥16,278 million |
| Full-year earnings forecast | Net Sales ¥33,500 million (YoY +2.5%) / Operating profit ¥1,400 million (YoY +7.7%) / Ordinary income ¥1,480 million (YoY +5.6%) / Net income ¥900 million (YoY -6.3%) |
| Annual Dividend Forecast | ¥29 → ¥30（+3.4%） |
| Segment revenue | Living business ¥12,247.53 thousand (YoY +23.6%), Aqua business ¥667.79 thousand (YoY +1.2%), Medical and Industrial Gases business ¥4,783.65 thousand (YoY +9.1%) |
| Segment profit | Living business ¥207.34 thousand (YoY +157.9%), Aqua business ¥33.42 thousand (YoY -26.3%), Medical and Industrial Gases business ¥335.24 thousand (YoY +45.5%) |
| Impairment loss | No applicable items |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥6,004 thousand / Extraordinary loss Loss on sale and disposal of non-current assets ¥14,153 thousand |
| Disclosure regarding the going concern assumption | No applicable items |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name No applicable items |
| Availability of Supplementary Financial Results Materials | None |
| Availability of Financial Results Briefing | None |
| Issued Shares at Period-End | 8,046,500 shares |
| Treasury Shares at Period-End | 347,445 treasury shares |
| Factors Behind Changes in Business Performance | Higher selling prices linked to LP gas procurement prices, increased LP gas shipment volumes, increased rentals of home healthcare equipment, and higher sales in the industrial gases and equipment division. |
Items this document does not state (12)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogDepreciation and amortizationMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Living Business, selling prices linked to LP gas procurement prices rose and shipment volumes increased. In the Medical and Industrial Gases Business, rentals of home healthcare equipment increased, as did sales in the industrial gases and equipment division. Overall, gross profit increased by more than selling, general and administrative expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.